UCPMP Brandon Medical India 2024-25

Brandon Medical India has officially published the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) for 2024-25. This latest edition of the UCPMP sets forth comprehensive guidelines designed to regulate pharmaceutical products’ ethical promotion and marketing in India. The new code emphasizes transparency, accountability, and fair practices within the industry, reinforcing pharmaceutical companies’ commitment to ethical standards.

The 2024-25 UCPMP introduces updated provisions on digital marketing, interactions with healthcare professionals, and the disclosure of financial relationships. It aims to foster trust between the industry and the public, ensuring that marketing practices prioritize patient welfare and ethical business conduct.

Brandon Medical India’s leadership expressed confidence that the new code will play a vital role in enhancing the pharmaceutical sector’s reputation and strengthening its regulatory framework. The UCPMP 2024-25 is now available for download on the company’s official website.